Events & presentations

EHA2023 Hybrid Congress

Cereno will attend and participate at the European Hematology Association's EHA2023 Hybrid Congress in Frankfurt, Germany, on June 8-11, 2023.

BioStock Life Science Summit 2023

Cereno participates with a company presentation at BioStock's Life Science Spring Summit on May 30-31 2023.

Aktiespararna’s Aktiedagen

Sten R. Sörensen, Chief Executive Officer (CEO) at Cereno, and Björn Dahlöf, Chief Medical Officer (CMO) will participate in the...

Vascular Discovery 2023: From Genes to Medicine

Vascular Discovery 2023: From Genes to Medicine hosted by the American Heart Association, in Boston, Massachusetts, US, May 10-13, 2023....

ACC.23/WCC

The American College of Cardiology joins with the World Heart Federation to host ACC.23 together with WCC (ACC.23/WCC) in New Orleans, LA,...

Global Cardiovascular Clinical Trialists (CVCT) Forum 2022

Cereno participates and presents at the 19th Global CVCT Forum 2022 on December 1-3, 2022, in Washington D.C. The event...

Redeye Life Science Day

BioStock Investor Day

Capital Markets Day 2022

Cereno invites analysts, investors, and financial media to a capital markets day to gain insights into our strategy and operations.

ESC Congress 2022

Cereno will present the abstract “CS014 is a novel HDAC inhibitor regulating platelet activity, fibrinolysis and clot stability for prevention...

15th Annual World Congress on Pulmonary Vascular Disease

Cereno will present the abstract “Investigation of efficacy, safety and optimal dose of CS1 in subjects with pulmonary arterial hypertension:...

Småbolagsdagarna 2022

Cereno participates in the Småbolagsdagarna organized by Aktiespararna on June 13-14, 2022.

EHA 2022 Hybrid Congress

Cereno will present the abstract "CS585 is a first-in-class compound targeting the IP receptor for prevention of thrombosis without increased...

BioStock Life Science Spring Summit 2022

Cereno participates with a company presentation at BioStock's Life Science Spring Summit on June 8-9, 2022.

Redeye Growth Day 2022

Cereno participates at Redeye Growth Day 2022. From the organizers: For the sixth consecutive year, Redeye will arrange Growth Day....

Annual General Meeting 2022

More information >

ABGSC Life Science Summit

Cereno participates in the ABG Sundal Collier Life Science Summit on Thursday, May 19, 2022. The event is for ABG...

Webcast focused on Phase II study with drug candidate CS1 in PAH

Cereno's Chief Executive Officer Sten R. Sörensen and Chief Medical Officer Dr. Björn Dahlöf will be joined by Dr. Raymond...

Global Cardiovascular Clinical Trialists Forum 2021

Cereno participates and presents at the18th Global Cardiovascular Clinical Trialists Forum on December 4, 2021.

Aktiespararnas Stora Aktiedagen

Cereno participates with a company presentation at Aktiespararnas Stora Aktiedagen on December 1, 2021.

Interim report Q3 2021

Redeye Life Science Day 2021

Cereno participates with a company presentation at Redeye Life Science Day 2021 in November 11.

BioStock Life Science Summit 2021

Cereno participates with a company presentation at BioStock Life Science Summit den 20-21 october.

Half-year report (Q2) 2021

Annual General Meeting 2021

Småbolagsdagarna 2021

Cereno participates in the Småbolagsdagarna organized by Aktiespararna on June 7-8, 2021.

Redeye Growth Day 2021

Cereno participates at Redeye Growth Day 2021, a live broadcasted event with over 60 selected companies within the Life Science...

BioStock Life Science Spring Summit 2021

Cereno participates with a company presentation at BioStock's Life Science Spring Summit on May 26-27, 2021.

NLSD 2021

Cereno is participating in the largest Nordic partnering conference dedicated to the life science industry.

Year-end report (Q4) 2020

LSX World Congress Virtual 2021

The premier event for leaders in life sciences investment, partnering, technology, business and strategy.

Biotech Showcase 2021

Cereno is participating at the US-focused partnering conference Biotech Showcase, held in conjunction with the J.P. Morgan 39th Annual Healthcare...

Interim report Q3 2020

BioStocks Life Science Summit 2020

Sten R. Sörensen, CEO, presents the company at 13.35 on November 18. The event is digital.

Bio-Europe Digital 2020

BIO-Europe Digital 2020 Cereno is participating at the global partnering conference Bio-Europe Digital.

BioStock Live Event

CEO Sten R. Sörensen will present the company with its revised clinical strategy for CS1 in rare disease PAH at...

BioPharm America, part of Biotech Week Boston

BioPharm America, part of Biotech Week Boston CEO Sten R. Sörensen will attend the 12th annual BioPharm America, part of Biotech...

Half-year report (Q2) 2020

LSX World Congress

LSX World Congress CEO Sten R. Sörensen will attend the LSX World Congress USA 2019 in Bostona. Contact Sten R....

Biotech Showcase™ 2020

Biotech Showcase™ 2020 On January 13-15 2020, CEO Sten R. Sörensen will participate at the Biotech Showcase in San Francisco,...

LeadingBiotech: East/West CEO

LeadingBiotech: East/West CEO CEO Sten R. Sörensen will attend East/West CEO in San Francisco, USA, on January 11-12 2020. Read...

16th Global Cardiovascular Clinical Trialists Forum

16th Global Cardiovascular Clinical Trialists Forum Faiez Zannad and Bertram Pitt, members of Cereno Scientific’s Advisory Board, are co-chairing the...

Nordic-American Life Sciences Conference 2019

Nordic-American Life Science Conference 2019 CEO Sten R. Sörensen will attend the Nordic-American Life Science Conference 2019 in New York...

LSX World Congress USA 2019

LSX World Congress USA CEO Sten R. Sörensen will attend the LSX World Congress USA 2019 in Bostona. Contact Sten...

Nordic Life Science Days 2019

Nordic Life Science Days 2019 Contact CMO Björn Dahlöf at bjorn.dahlof@cerenoscientific.com to schedule a meeting. Read more about the event here

ESC Congress 2019 together with World Congress of Cardiology

ESC Congress 2019 together with World Congress of Cardiology CEO Sten R. Sörensen and CMO Björn Dahlöf will attend the...

ISTH 2019 Congress

ISTH 2019 Congress Presentation of Cereno Scientific’s abstract “A New Treatment for Thrombosis Prevention?”. The results will be presented by...

American College of Cardiology’s 68th Annual Scientific Session & Expo

American College of Cardiology’s 68th Annual Scientific Session & Expo Contact Sten R. Sörensen on +46 (0) 733 74 03...

Jefferies 2018 London Healthcare Conference

Jefferies 2018 London Healthcare Conference Cereno Scientific will attend at Jefferies 2018 London Healthcare Conference. Contact Sten R. Sörensen on...

Biotech and money, showcase 2018

Biotech and money, showcase 2018 Cereno presents at Biotech and money, Investival showcase 2018. Contact Sten R. Sörensen on +46...

BIO-Europe 2018

BIO-Europe 2018 Cereno Scientific will attend at BIO-Europe 2018. Contact Sten R. Sörensen on +46 (0) 733 74 03 74...

Biostock live, Stockholm

Biostock live, Stockholm Cereno presents at Biostock live in Stockholm, on the 13th of September. Read more or sign up...

Nordic Life Science Days 2018

Nordic Life Science Days 2018 Cereno Scientific will attend the Nordic Life Science Days. Contact Sten R. Sörensen on +46 (0)...

LSX Nordic 2018

LSX Nordic 2018 Cereno Scientific will attend the Nordic Life Science Days. Contact Sten R. Sörensen on +46 (0) 733...

Redeye Growth Day, Scandic Haymarket Stockholm

Redeye Growth Day, Scandic Haymarket Stockholm Cereno presentation, 2.05 pm at the Redeye Growth Day, Scandic Haymarket Stockholm Read more...

Investor presentation ’’Companies of the future’’

Investor presentation ’’Companies of the future’’ Cereno investor presentation, 5.55 pm in Göteborg ’’Companies of the future’’ in collaboration with...

BIO-Europe 2017

BIO-Europe 2017 Cereno Scientific will attend BIO-Europe 2017. Contact Sten R. Sörensen on +46 (0) 733 74 03 74 or sten.sorensen@cerenoscientific.com to schedule...

Nordic Life Science Days 2017

Nordic Life Science Days 2017 Cereno Scientific will attend the Nordic Life Science Days. Contact Sten R. Sörensen on +46 (0) 733...